These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1657582)

  • 1. Thyrotropin-releasing hormone stimulation of phosphoinositide hydrolysis desensitizes. Evidence against mediation by protein kinase C or calcium.
    Perlman JH; Gershengorn MC
    Endocrinology; 1991 Nov; 129(5):2679-86. PubMed ID: 1657582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin-releasing hormone (TRH) and phorbol myristate acetate decrease TRH receptor messenger RNA in rat pituitary GH3 cells: evidence that protein kinase-C mediates the TRH effect.
    Fujimoto J; Straub RE; Gershengorn MC
    Mol Endocrinol; 1991 Oct; 5(10):1527-32. PubMed ID: 1723145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for tight coupling of receptor occupancy by thyrotropin-releasing hormone to phospholipase C-mediated phosphoinositide hydrolysis in rat pituitary cells: use of chlordiazepoxide as a competitive antagonist.
    Gershengorn MC; Paul ME
    Endocrinology; 1986 Aug; 119(2):833-9. PubMed ID: 3015558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttranscriptional up-regulation of thyrotropin-releasing hormone (TRH) receptor messenger ribonucleic acid by TRH in COS-1 cells transfected with mouse pituitary TRH receptor complementary deoxyribonucleic acid.
    Fujimoto J; Narayanan CS; Benjamin JE; Gershengorn MC
    Endocrinology; 1992 Oct; 131(4):1716-20. PubMed ID: 1327718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidylinositol depletion in GH3 rat pituitary cells inhibits sustained responses to thyrotropin-releasing hormone. Reversal with myo-inositol.
    Rodriguez R; Imai A; Gershengorn MC
    Mol Endocrinol; 1987 Nov; 1(11):802-7. PubMed ID: 3155260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin (TSH)-releasing hormone stimulates TSH beta promoter activity by two distinct mechanisms involving calcium influx through L type Ca2+ channels and protein kinase C.
    Shupnik MA; Weck J; Hinkle PM
    Mol Endocrinol; 1996 Jan; 10(1):90-9. PubMed ID: 8838148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thyrotropin-releasing hormone on phosphoinositides and cytoplasmic free calcium in thyrotropic pituitary cells.
    Brenner-Gati L; Gershengorn MC
    Endocrinology; 1986 Jan; 118(1):163-9. PubMed ID: 3000732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin-releasing hormone stimulation of prolactin secretion is coordinately but not synergistically regulated by an elevation of cytoplasmic calcium and 1,2-diacylglycerol.
    Kolesnick RN; Gershengorn MC
    Endocrinology; 1986 Dec; 119(6):2461-6. PubMed ID: 3096691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C inhibits TRH-stimulated phosphoinositide hydrolysis in GH3 cells.
    Sortino M; Canonico PL; Summers ST; Cronin MJ
    Eur J Pharmacol; 1987 Mar; 135(1):77-83. PubMed ID: 3032661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin-releasing hormone-stimulated [3H]inositol metabolism in GH3 pituitary tumor cells. Studies with lithium.
    Drummond AH; Bushfield M; Macphee CH
    Mol Pharmacol; 1984 Mar; 25(2):201-8. PubMed ID: 6321943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
    Aizawa T; Hinkle PM
    Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of pituitary polyphosphoinositide metabolism by protein kinase C activation.
    Judd AM; Jarvis WD; MacLeod RM
    Mol Cell Endocrinol; 1987 Dec; 54(2-3):107-14. PubMed ID: 2826275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse agonist abolishes desensitization of a constitutively active mutant of thyrotropin-releasing hormone receptor: role of cellular calcium and protein kinase C.
    Grimberg H; Zaltsman I; Lupu-Meiri M; Gershengorn MC; Oron Y
    Br J Pharmacol; 1999 Mar; 126(5):1097-106. PubMed ID: 10204996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the Ca2+ spike and oscillations induced by different doses of thyrotropin-releasing hormone (TRH) in individual pituitary cells and nonexcitable cells transfected with TRH receptor complementary deoxyribonucleic acid.
    Nelson EJ; Hinkle PM
    Endocrinology; 1994 Sep; 135(3):1084-92. PubMed ID: 8070350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone receptor occupancy determines the fraction of the responsive pool of inositol lipids hydrolysed in rat pituitary tumour cells.
    Cubitt AB; Geras-Raaka E; Gershengorn MC
    Biochem J; 1990 Oct; 271(2):331-6. PubMed ID: 2173558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling of bradykinin-induced phosphoinositide hydrolysis and Ca2+ mobilization by phorbol ester in canine cultured tracheal epithelial cells.
    Yang CM; Luo SF; Wu WB; Pan SL; Tsai YJ; Chiu CT; Wang CC
    Br J Pharmacol; 1998 Oct; 125(4):627-36. PubMed ID: 9831895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 5-hydroxytryptamine-induced phosphoinositide hydrolysis and Ca2+ mobilization in canine cultured tracheal smooth muscle cells by phorbol ester.
    Yang CM; Fen LW; Tsao HL; Chiu CT
    Br J Pharmacol; 1997 Jul; 121(5):853-60. PubMed ID: 9222540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of thyrotropin-releasing hormone receptors is cell type specific: comparison of endogenous pituitary receptors and receptors transfected into non-pituitary cells.
    Gershengorn MC; Thaw CN
    Endocrinology; 1991 Feb; 128(2):1204-6. PubMed ID: 1846583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 12-O-tetradecanoyl-phorbol-13-acetate decreases influx of extracellular Ca2+ induced by depolarization in GH4C1 cells: effects of pretreatment with 1,25-dihydroxycholecalciferol.
    Tornquist K; Tashjian AH
    Endocrinology; 1990 Apr; 126(4):2068-78. PubMed ID: 1690636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin-releasing hormone and epidermal growth factor stimulate prolactin synthesis by a pathway(s) that differs from that used by phorbol esters: dissociation of actions by calcium dependency and additivity.
    Ramsdell JS; Tashjian AH
    Endocrinology; 1985 Nov; 117(5):2050-60. PubMed ID: 3930223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.